133 related articles for article (PubMed ID: 23847189)
21. Plasmacytoid dendritic cells in skin lesions of classic Kaposi's sarcoma.
Karouni M; Kurban M; Abbas O
Arch Dermatol Res; 2016 Sep; 308(7):487-92. PubMed ID: 27372661
[TBL] [Abstract][Full Text] [Related]
22. HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells.
Florentin J; Aouar B; Dental C; Thumann C; Firaguay G; Gondois-Rey F; Soumelis V; Baumert TF; Nunès JA; Olive D; Hirsch I; Stranska R
Blood; 2012 Nov; 120(23):4544-51. PubMed ID: 23053572
[TBL] [Abstract][Full Text] [Related]
23. CD303 (BDCA-2) - a potential novel target for therapy in hematologic malignancies.
Wilson NR; Bover L; Konopleva M; Han L; Neelapu S; Pemmaraju N
Leuk Lymphoma; 2022 Jan; 63(1):19-30. PubMed ID: 34486917
[TBL] [Abstract][Full Text] [Related]
24. Signaling and immune regulatory role of the dendritic cell immunoreceptor (DCIR) family lectins: DCIR, DCAR, dectin-2 and BDCA-2.
Kanazawa N; Tashiro K; Miyachi Y
Immunobiology; 2004; 209(1-2):179-90. PubMed ID: 15481152
[TBL] [Abstract][Full Text] [Related]
25. Plasmacytoid dendritic cell subpopulations in head and neck squamous cell carcinoma.
Thiel A; Kesselring R; Pries R; Wittkopf N; Puzik A; Wollenberg B
Oncol Rep; 2011 Sep; 26(3):615-20. PubMed ID: 21687955
[TBL] [Abstract][Full Text] [Related]
26. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction.
Dzionek A; Sohma Y; Nagafune J; Cella M; Colonna M; Facchetti F; Günther G; Johnston I; Lanzavecchia A; Nagasaka T; Okada T; Vermi W; Winkels G; Yamamoto T; Zysk M; Yamaguchi Y; Schmitz J
J Exp Med; 2001 Dec; 194(12):1823-34. PubMed ID: 11748283
[TBL] [Abstract][Full Text] [Related]
27. Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions.
Dzionek A; Inagaki Y; Okawa K; Nagafune J; Röck J; Sohma Y; Winkels G; Zysk M; Yamaguchi Y; Schmitz J
Hum Immunol; 2002 Dec; 63(12):1133-48. PubMed ID: 12480257
[TBL] [Abstract][Full Text] [Related]
28. Expression of C-type lectin receptors by subsets of dendritic cells in human skin.
Ebner S; Ehammer Z; Holzmann S; Schwingshackl P; Forstner M; Stoitzner P; Huemer GM; Fritsch P; Romani N
Int Immunol; 2004 Jun; 16(6):877-87. PubMed ID: 15113774
[TBL] [Abstract][Full Text] [Related]
29. Identification of serum glycoprotein ligands for the immunomodulatory receptor blood dendritic cell antigen 2.
Kim JW; Budzak J; Liu Y; Jégouzo SAF; Drickamer K; Taylor ME
Glycobiology; 2018 Aug; 28(8):592-600. PubMed ID: 29796630
[TBL] [Abstract][Full Text] [Related]
30. BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation.
Jähn PS; Zänker KS; Schmitz J; Dzionek A
Cell Immunol; 2010; 265(1):15-22. PubMed ID: 20673884
[TBL] [Abstract][Full Text] [Related]
31. Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 (DC2) in allogeneic hematopoietic stem cell transplantation.
Arpinati M; Chirumbolo G; Urbini B; Martelli V; Stanzani M; Falcioni S; Bonifazi F; Bandini G; Tura S; Baccarani M; Rondelli D
Bone Marrow Transplant; 2002 Jun; 29(11):887-91. PubMed ID: 12080352
[TBL] [Abstract][Full Text] [Related]
32. HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells.
Xu Y; Hu Y; Shi B; Zhang X; Wang J; Zhang Z; Shen F; Zhang Q; Sun S; Yuan Z
Mol Immunol; 2009 Aug; 46(13):2640-6. PubMed ID: 19501403
[TBL] [Abstract][Full Text] [Related]
33. Plasmacytoid dendritic cells in cutaneous lesions of patients with chromoblastomycosis, lacaziosis, and paracoccidioidomycosis: a comparative analysis.
Pagliari C; Kanashiro-Galo L; Silva AA; Barboza TC; Criado PR; Duarte MI; Brito AC; Xavier MB; Unger D; Maria Moraes Oliveira C; Quaresma JA; Sotto MN
Med Mycol; 2014 May; 52(4):397-402. PubMed ID: 24782102
[TBL] [Abstract][Full Text] [Related]
34. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
[TBL] [Abstract][Full Text] [Related]
35. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of human immunodeficiency virus gp120 and Tat on CpG-A-induced inflammatory cytokines in plasmacytoid dendritic cells.
Fang M; Xu N; Shao X; Yang J; Wu N; Yao H
Acta Biochim Biophys Sin (Shanghai); 2012 Sep; 44(9):797-804. PubMed ID: 22814248
[TBL] [Abstract][Full Text] [Related]
37. Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood.
Van Brussel I; Van Vré EA; De Meyer GR; Vrints CJ; Bosmans JM; Bult H
J Immunol Methods; 2010 Oct; 362(1-2):168-75. PubMed ID: 20888334
[TBL] [Abstract][Full Text] [Related]
38. Running to stand still: BCR-like signaling suppresses type I IFN responses in pDC.
Swiecki MK; Colonna M
Eur J Immunol; 2007 Dec; 37(12):3327-9. PubMed ID: 18050162
[TBL] [Abstract][Full Text] [Related]
39. Receptor cross-linking on human plasmacytoid dendritic cells leads to the regulation of IFN-alpha production.
Fanning SL; George TC; Feng D; Feldman SB; Megjugorac NJ; Izaguirre AG; Fitzgerald-Bocarsly P
J Immunol; 2006 Nov; 177(9):5829-39. PubMed ID: 17056507
[TBL] [Abstract][Full Text] [Related]
40. Tumour infiltrating plasmacytoid dendritic cells in B cell post-transplant lymphoproliferative disorders, human immunodeficiency virus-associated B cell lymphomas and immune competent diffuse large B cell lymphomas.
Ibrahim HA; Menasce L; Pomplun S; Burke M; Bower M; Naresh KN
Histopathology; 2011 Jul; 59(1):152-6. PubMed ID: 21771035
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
